BAMCO Inc’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-50,500
Closed -$1.04M 335
2024
Q1
$1.04M Hold
50,500
﹤0.01% 304
2023
Q4
$1.08M Hold
50,500
﹤0.01% 301
2023
Q3
$1.04M Hold
50,500
﹤0.01% 297
2023
Q2
$1.49M Hold
50,500
﹤0.01% 302
2023
Q1
$1.16M Sell
50,500
-213,756
-81% -$4.92M ﹤0.01% 318
2022
Q4
$7.35M Sell
264,256
-10,606
-4% -$295K 0.02% 245
2022
Q3
$8.44M Sell
274,862
-843
-0.3% -$25.9K 0.03% 244
2022
Q2
$8.11M Sell
275,705
-379,643
-58% -$11.2M 0.03% 258
2022
Q1
$21.1M Sell
655,348
-340,956
-34% -$11M 0.05% 226
2021
Q4
$44.4M Sell
996,304
-131,615
-12% -$5.87M 0.09% 176
2021
Q3
$56.9M Sell
1,127,919
-127,305
-10% -$6.42M 0.13% 144
2021
Q2
$98.5M Buy
1,255,224
+45,400
+4% +$3.56M 0.23% 97
2021
Q1
$69.1M Buy
1,209,824
+146,418
+14% +$8.36M 0.17% 124
2020
Q4
$89.1M Buy
1,063,406
+105,200
+11% +$8.81M 0.22% 95
2020
Q3
$34.3M Buy
958,206
+5,249
+0.6% +$188K 0.11% 145
2020
Q2
$23M Hold
952,957
0.08% 162
2020
Q1
$16.7M Hold
952,957
0.08% 152
2019
Q4
$16.6M Sell
952,957
-31,705
-3% -$552K 0.06% 176
2019
Q3
$15.1M Hold
984,662
0.06% 178
2019
Q2
$20.4M Hold
984,662
0.08% 171
2019
Q1
$22.9M Buy
984,662
+760
+0.1% +$17.6K 0.1% 164
2018
Q4
$20.3M Buy
983,902
+28,500
+3% +$589K 0.1% 162
2018
Q3
$20.8M Buy
955,402
+9,940
+1% +$216K 0.09% 171
2018
Q2
$14.4M Buy
945,462
+31,937
+3% +$487K 0.06% 188
2018
Q1
$18M Buy
913,525
+423,525
+86% +$8.34M 0.08% 178
2017
Q4
$7.66M Buy
+490,000
New +$7.66M 0.04% 211